1. Home
  2. UTSI vs NCEL Comparison

UTSI vs NCEL Comparison

Compare UTSI & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo UTStarcom Holdings Corp.

UTSI

UTStarcom Holdings Corp.

N/A

Current Price

$2.30

Market Cap

23.7M

ML Signal

N/A

NCEL

NewcelX Ltd. Ordinary Shares

N/A

Current Price

$2.79

Market Cap

20.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UTSI
NCEL
Founded
1991
2008
Country
China
Switzerland
Employees
N/A
N/A
Industry
Telecommunications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.7M
20.7M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
UTSI
NCEL
Price
$2.30
$2.79
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
3.1K
89.0K
Earning Date
08-29-2025
12-01-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$9,793,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.84
$2.48
52 Week High
$3.00
$7.64

Technical Indicators

Market Signals
Indicator
UTSI
NCEL
Relative Strength Index (RSI) 44.35 N/A
Support Level $2.00 N/A
Resistance Level $2.55 N/A
Average True Range (ATR) 0.07 0.00
MACD -0.03 0.00
Stochastic Oscillator 54.55 0.00

Price Performance

Historical Comparison
UTSI
NCEL

About UTSI UTStarcom Holdings Corp.

UTStarcom Holdings Corp is providing telecommunication network products, solutions and services. It focus on delivering carrier-class packet optical, network synchronization and broadband access (both wireless and fixed line) products and solutions, coupled with Software Defined Networking (SDN) platform, optimized for mobile backhaul, metro aggregation, broadband access and value added services. The business activity of the firm is operated through the Equipment and Service segment. The Equipment segment is focused on equipment sales, including network infrastructure and application products, and the Service segment is engaged in providing services and support of equipment products and also the new operational support. Key revenue is generated from Equipment segment.

About NCEL NewcelX Ltd. Ordinary Shares

NewcelX Ltd is a biotechnology company developing transformative cell-based and small-molecule therapies for neurodegenerative and metabolic diseases. The company's integrated platform combines advanced stem-cell technologies and neuroscience expertise to deliver scalable, regenerative treatments targeting conditions such as Amyotrophic Lateral Sclerosis (ALS) and Type 1 Diabetes. It has research and development operations in Ness Ziona, Israel.

Share on Social Networks: